These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 14968505

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Health risks after cessation of postmenopausal hormone therapy.
    Pines A, Sturdee D, Birkhäuser M, International Menopause Society.
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis].
    Urano T.
    Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770
    [Abstract] [Full Text] [Related]

  • 4. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP.
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [Abstract] [Full Text] [Related]

  • 5. [Benefits and risks in hormone substitute therapy in postmenopause].
    Baljić T.
    Srp Arh Celok Lek; 1996 Apr; 124(5-6):143-6. PubMed ID: 9102835
    [Abstract] [Full Text] [Related]

  • 6. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G.
    Rep Med Guidel Outcomes Res; 2002 Aug 09; 13(15):5-7. PubMed ID: 12553323
    [No Abstract] [Full Text] [Related]

  • 7. Menopausal hormone replacement therapy.
    Varner RE.
    Curr Womens Health Rep; 2003 Oct 09; 3(5):410-7. PubMed ID: 12959701
    [Abstract] [Full Text] [Related]

  • 8. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force.
    Ann Intern Med; 2002 Nov 19; 137(10):I48. PubMed ID: 12435233
    [No Abstract] [Full Text] [Related]

  • 9. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Mikkola TS, Clarkson TB, Notelovitz M.
    Ann Med; 2004 Nov 19; 36(6):402-13. PubMed ID: 15513292
    [Abstract] [Full Text] [Related]

  • 10. [Benefits and risks of postmenopausal hormone replacement therapy. Symptoms improved but not a better outcome?].
    MMW Fortschr Med; 2010 Jun 17; 152(24):18. PubMed ID: 20672580
    [No Abstract] [Full Text] [Related]

  • 11. Practical guidelines for postmenopausal hormone therapy.
    Speroff L, Kenemans P, Burger HG.
    Maturitas; 2005 May 16; 51(1):4-7. PubMed ID: 15883102
    [Abstract] [Full Text] [Related]

  • 12. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of the American Society for Reproductive Medicine.
    Fertil Steril; 2006 Nov 16; 86(5 Suppl 1):S75-88. PubMed ID: 17055850
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
    Higuchi T, Mizunuma H.
    Clin Calcium; 2004 Oct 16; 14(10):81-4. PubMed ID: 15577136
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.